JPRN-UMIN000016463已完成未知
A randomized double-blind placebo-controlled trial for improving the intestinal environment in human - A trial for improving the intestinal environment in human
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 59years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •a) Persons who have previous medical history of malignant tumor or heart failure or myocardial infarction b) Patients being treated for at least one of following diseases atrial fibrillation, cardiac arrhythmia, hepatic disorder, renal disorder, cerebrovascular disorder, rheumatism, diabetes mellitus, dyslipidemia, hypertension and other chronic disease c) Persons who take medicines, herbal medicines, or supplement. d) Persons who are allergic to medicines, or products related to the test material of this trial e) Persons who habitually take foods that seem to be influential on intestinal environment, e.g., FOSHU, yogurt, and lactic fermenting beverage f) Persons who smoke g) Pregnant women, lactating women, or women who want to get pregnant during the trial period h) Persons who have been enrolled in the other clinical trials within last 3 months before the agreement for the participation to this trial i) Persons who are judged unsuitable to participate in this trial by physician
研究者
相似试验
已完成
不适用
A randomized double-blind placebo-controlled trial for improving the intestinal environment in humaJPRN-UMIN000018958ORTHOMEDICO, Inc.24
招募中
1 期
A randomized double-blind placebo-controlled study of Xianghua Compound Granule in the treatment of liver depression type insomniaiver depression type insomniaITMCTR2000003568Shanghai Traditional Chinese Medicine Hospital
已完成
4 期
A randomized double-blind placebo-controlled trial to assess the effects of 17 beta-oestradiol 1mg + drospirenone 2mg administration on cognitive function in early postmenopausal women.cognitionNeurological - Other neurological disordersACTRN12608000201370Women's Health Program, Monash University40
已完成
不适用
Gut Bugs Trial - Gut microbiome transfer for the treatment of adolescent obesityACTRN12615001351505niversity of Auckland87
尚未招募
3 期
A randomized double-blind placebo-controlled trial of oral ivermectin for outpatient treatment of those at high risk for hospitalization due to COVID-19ACTRN12620000982910euroscience Trials Australia400